MAPK6 and familial pancreatic carcinoma: Analysis of The Cancer Genome Atlas (TCGA) datasets indicated a progressive increase in ERK3 expression levels with the advancing stage of pancreatic cancer (Figure 2D), and that pancreatic cancer patients with poor prognosis have high ERK3 expression (Figure 2E).